Skip Navigation


JAC Advance Access originally published online on May 12, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
54/1/247    most recent
dkh250v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Buxbaum, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buxbaum, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy 2004 54(1):247-250; doi:10.1093/jac/dkh250
JAC vol.54 no.1 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in Austria

Astrid Buxbaum1, Sabine Forsthuber2, Wolfgang Graninger2 and Apostolos Georgopoulos2,* on behalf of The Austrian Bacterial Surveillance Network{dagger}

1 Department of Internal Medicine IV, Division of Pulmology, and 2 Department of Internal Medicine I, Division of Infectious Diseases and Chemotherapy, University of Vienna, Währinger Gürtel 18–20, 1090 Vienna, Austria

* Corresponding author. Tel: +43-1-40400-5139; Fax: +43-1-40400-5200; Email: apostolos.georgopoulos{at}akh-wien.ac.at

Objectives: To determine the prevalence of antibiotic resistance and the distribution of serotypes among Streptococcus pneumoniae isolated in Austria.

Materials and methods: A total of 2367 strains of S. pneumoniae were collected in an Austrian-wide surveillance system between 1996 and 2002. Isolates were tested for their susceptibility to penicillin and clarithromycin and were serotyped by the capsular swelling method.

Results: An overall rise in penicillin resistance was observed from 4.9% in 1996 to 10.0% in 2002 (including both intermediate-resistant and resistant strains). A rise in clarithromycin resistance was also recorded in this period. The overall distribution of serogroups/types remained relatively stable, with 23, 19, 6 and 14 being the most frequent ones. Whereas in 1996 penicillin resistance was predominantly associated with serotype 23F, in 1998 and 2002, resistance was most frequently found in isolates of serogroup 9 and serotype 14, respectively. Coverage rates for currently available vaccines ranged from 57.4% (7-valent) to 72.4% (23-valent) of all serotyped strains.

Conclusions: This rise in pneumococcal resistance to penicillin and clarithromycin, and the change in distribution of serotypes in these resistant strains, indicates that ongoing surveillance programmes are warranted, in order to be able to formulate both effective vaccination strategies and optimal antibiotic therapies.

Keywords: serogroups , pneumococci , adults , vaccines


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Med MicrobiolHome page
H. Zemlickova, O. Melter, and P. Urbaskova
Epidemiological relationships among penicillin non-susceptible Streptococcus pneumoniae strains recovered in the Czech Republic.
J. Med. Microbiol., April 1, 2006; 55(Pt 4): 437 - 442.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.